{
  "id": "cluster_4_doc4",
  "content": "Chicago Tribune health section article (December 2023): Northwestern Medicine pioneering new dual-targeted therapy approach for histiocytosis patients. Mentions ongoing IMPACT-09 trial coordinator Dr. Rajiv Varma and 68-year-old participant achieving partial remission.",
  "metadata": {
    "format": "news_article"
  }
}